These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23163346)

  • 21. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas.
    Moriguchi J; Inoue Y; Kamiyama S; Horiguchi M; Murata K; Sakuragi S; Fukui Y; Ohashi F; Ikeda M
    Toxicol Lett; 2009 Oct; 190(1):1-8. PubMed ID: 19467302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin dose rate as a risk factor for nephrotoxicity in children.
    Skinner R; Pearson AD; English MW; Price L; Wyllie RA; Coulthard MG; Craft AW
    Br J Cancer; 1998 May; 77(10):1677-82. PubMed ID: 9635848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
    Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prophylactic effect of ulinastatin on cisplatin-induced renal disorders in lung cancer patients].
    Horiguchi T; Kasahara J; Ogura K; Handa M; Hosoda H; Shakato A; Tachikawa S; Sato M; Suetsugu S; Umeda H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):12-9. PubMed ID: 1625386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tubular and glomerular function in children after renal transplantation.
    Dagan A; Eisenstein B; Bar-Nathan N; Cleper R; Krause I; Smolkin V; Davidovits M
    Pediatr Transplant; 2005 Aug; 9(4):440-4. PubMed ID: 16048594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical multivariate statistical analysis of nephrotoxicity induced by cisplatin].
    Ding DC
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):64-6. PubMed ID: 1396050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
    Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
    Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute nephrotoxicity by CDDP (on tubular damage)].
    Higuchi K; Negoro Y; Suzuki M; Noguchi M; Nakanishi M; Ishihara M; Nakano M
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):85-9. PubMed ID: 1987905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors.
    Bosl GJ; Leitner SP; Atlas SA; Sealey JE; Preibisz JJ; Scheiner E
    J Clin Oncol; 1986 Nov; 4(11):1684-9. PubMed ID: 3021923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney function tests in children with beta-thalassemia minor in Zahedan, southeast of Iran.
    Sadeghi-Bojd S; Hashemi M; Naderi M; Shikhani S
    Iran J Kidney Dis; 2011 Jul; 5(3):201-3. PubMed ID: 21525581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of methotrexate nephrotoxicity after cisplatin therapy.
    Goren MP; Wright RK; Horowitz ME; Meyer WH
    Cancer; 1986 Dec; 58(12):2617-21. PubMed ID: 2877729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin.
    La Manna G; Virzì S; Deraco M; Capelli I; Accorsi A; Dalmastri V; Comai G; Bonomi S; Grassi A; Selva S; Feliciangeli G; Scolari M; Stefoni S
    In Vivo; 2006; 20(6A):703-6. PubMed ID: 17203749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
    Ujiie T; Maruta H; Ito N
    Hinyokika Kiyo; 1988 May; 34(5):790-6. PubMed ID: 2459938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin-induced nephrotoxicity and the protective effect of fosfomycin on it as demonstrated by using a crossover study of urinary metabolite levels.
    Hayashi M; Numaguchi M; Watabe H; Enomoto H; Yaoi Y
    Acta Obstet Gynecol Scand; 1997 Jul; 76(6):590-5. PubMed ID: 9246969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients.
    Hu YJ; Chen Y; Zhang YQ; Zhou MZ; Song XM; Zhang BZ; Luo L; Xu PM; Zhao YN; Zhao YB; Cheng G
    Biol Trace Elem Res; 1997 Mar; 56(3):331-41. PubMed ID: 9197929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cis-platinum and distal renal tubule toxicity.
    Swainson CP; Colls BM; Fitzharris BM
    N Z Med J; 1985 May; 98(779):375-8. PubMed ID: 2986064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The excretion of urinary enzymes, proteins and creatinine in patients receiving cisplatinum.
    Nekulová M; Mechl Z; Kerpel-Fronius S; Skalková D; Sopková B
    Neoplasma; 1987; 34(2):183-8. PubMed ID: 2885765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.